Naturasil
- Manufacturer
- Nature's Innovation, Inc.
- Effective date
- 2021-01-14
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 4
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 22:56:33
Label at a glance#
Contacts and useful links#
Label contents#
Full prescribing information#
OTC - ACTIVE INGREDIENT SECTION
Drug Facts
Active Ingredients
Thuja Occidentalis 6X HPUS
DESCRIPTION SECTION
The letters HPUS indicate the component(s) in this product is (are) officially monographed in the Homeopathic Pharmacopeia of the United States.
OTC - PURPOSE SECTION
Purpose
Polypi and Naevi Symptom Relief
INDICATIONS & USAGE SECTION
Uses: Symptomatic treatment of molluscum contagiosum.
WARNINGS SECTION
Warnings: For external use only.
OTC - ASK DOCTOR SECTION
Ask a doctor before use if pregnant or nursing.
OTHER SAFETY INFORMATION
Avoid using near eyes or mouth.
OTC - KEEP OUT OF REACH OF CHILDREN SECTION
Keep out of reach of children.
OTC - DO NOT USE SECTION
Do not use if tamper evident seal is broken.
OTHER SAFETY INFORMATION
In case of ingestion call Poison Control Center hotline immediately at 1-800-222-1222.
DOSAGE & ADMINISTRATION SECTION
Directions: Thoroughly wash and dry area. Apply 3-4 times daily to affected area. Molluscum will diminish and flake away over 2-6 weeks depending on severity of condition. Some individuals may be sensitive to essential oils. Skin test for tolerability. If irritation or reaction occurs, discontinue use.
INACTIVE INGREDIENT SECTION
Inactive Ingredients: Cedar Leaf Oil, Melaleuca Alternifolia Leaf Oil, Ricinus Communis Seed Oil.
OTC - QUESTIONS SECTION
Questions? Comments?
www.naturasil.com 1-866-371-2499
Mfd. by: Nature's Innovation, Inc.,
2723 Brickton North Dr., Buford, GA 30518
Not tested on animals.
PACKAGE LABEL.PRINCIPAL DISPLAY PANEL
100%
Natural Plant
Extracts
Naturasil
ml ( fl.oz.)
Topical Liquid
Homeopathic Medicine
Molluscum
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE INGREDIENT | 1NT28V9397 | 2 | |
| THUJA OCCIDENTALIS LEAFY TWIG | ACTIVE MOIETY | 1NT28V9397 | 2 | |
| CASTOR OIL | INACTIVE INGREDIENT | D5340Y2I9G | 2 | |
| CEDAR LEAF OIL | INACTIVE INGREDIENT | BJ169U4NLG | 2 | |
| TEA TREE OIL | INACTIVE INGREDIENT | VIF565UC2G | 2 |
Products#
Every source-derived product name is available through these pages.
- Naturasil Molluscum
- Thuja Occidentalis
- THUJA OCCIDENTALIS LEAFY TWIG
- CEDAR LEAF OIL
- TEA TREE OIL
- CASTOR OIL
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 10893-500 | 10893-500-10, 10893-500-50, 10893-500-15 |
Ingredients#
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| THUJA OCCIDENTALIS LEAFY TWIG | 1NT28V9397 | ACTIB |
| CEDAR LEAF OIL | BJ169U4NLG | IACT |
| TEA TREE OIL | VIF565UC2G | IACT |
| CASTOR OIL | D5340Y2I9G | IACT |
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | GEL / NASAL | 429 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | CAPSULE, EXTENDED RELEASE / ORAL | 47 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | OINTMENT / TOPICAL | 14.9 %w/w | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | SPRAY / NASAL | NA | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | SOLUTION / TOPICAL | 1.38 %w/w | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, EXTENDED RELEASE / ORAL | 23.27 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, DELAYED RELEASE / ORAL | 0.01 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, FILM COATED / ORAL | 15.29 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET / ORAL | 17 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | GRANULE, FOR SUSPENSION / ORAL | 128 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | INJECTION, SOLUTION / INTRAMUSCULAR | 525 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | EMULSION / OPHTHALMIC | 32 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | INJECTION / INTRAMUSCULAR | 885 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET / SUBLINGUAL | 1.6 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | TABLET, COATED / ORAL | 0.9 mg | ||
| CASTOR OIL | CASTOR OIL | D5340Y2I9G | CAPSULE / ORAL | 1.04 mg |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 2bb5f0a6-56bd-45ed-9093-c6f927fd2cab | bc956746-9df5-4fc1-ac21-44df906eb2ba | 2024-06-06 | Warnings | bc956746-9df5-4fc1-ac21-44df906eb2ba |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.



